CARL WILLEFORD: Open Payments
NPI 1063465409 · NACOGDOCHES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,755 in 103 payments from 21 companies in 2025. Trend: 2023 $1,466 · 2024 $1,329 · 2025 $1,755
Food & beverage: $1,755
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $272 |
| Otsuka America Pharmaceutical, Inc. | 11 | $218 |
| AstraZeneca Pharmaceuticals LP | 13 | $218 |
| Amgen Inc. | 14 | $174 |
| Novo Nordisk Inc | 11 | $149 |
| Lilly USA, LLC | 8 | $136 |
| Axsome Therapeutics, Inc. | 4 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Lundbeck LLC | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
Products named: REXULTI, VRAYLAR, BREZTRI, REPATHA, JARDIANCE, Kerendia, AIRSUPRA, QULIPTA.
Industry payments across TX — which companies pay providers there.
